Teva Pharmaceutical Indus Q3 Adj. EPS $0.86 Beats $0.73 Estimate, Sales $4.395B Beat $4.291B Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.73 by 17.81 percent. This is a 10.26 percent increase over earnings of $0.78 per share
Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.73 by 17.81 percent. This is a 10.26 percent increase over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $4.395 billion which beat the analyst consensus estimate of $4.291 billion by 2.42 percent. This is a 1.90 percent decrease over sales of $4.480 billion the same period last year.